FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Yang Gang CBPO

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/16/2013 

3. Issuer Name and Ticker or Trading Symbol

China Biologic Products, Inc. [CBPO]

(Last)        (First)        (Middle)

C/O CBPO, 18F, JIALONG INT'L TOWER,, 19 CHAOYANG PARK RD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Corporate Vice President /

(Street)

BEIJING, F4 100125       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Restricted Stock   (1) 5000   D    
Restricted Stock   (2) 20000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (3)   (3) 7/11/2020   Common Stock   40000   (3) $12.26   D    
Stock Option (right to buy)   (4)   (4) 8/31/2022   Common Stock   15000   (4) $9.85   D    

Explanation of Responses:
( 1)  Represents the grant of restricted stock to the Reporting Person, under the Issuer's 2008 equity incentive plan (the "2008 Plan"), pursuant to a restricted stock grant agreement dated August 31, 2012 (the "2012 Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a 48-month period in four equal portions, with an initial vesting date on September 1, 2013, provided that the Reporting Person has been continuously a Service Provider (as defined in the 2012 Restricted Stock Agreement) from August 31, 2012 until the date such vesting occurs.
( 2)  Represents the grant of restricted stock to the Reporting Person under the 2008 plan, pursuant to a restricted stock award agreement dated August 16, 2013 (the "2013 Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a 48-month period in four equal portions, with an initial vesting date on August 16, 2014, provided that the Reporting Person has been continuously a Service Provider (as defined in the 2013 Restricted Stock Agreement) from August 16, 2013 until the date such vesting occurs.
( 3)  Represents ten year non-qualified stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the 2008 Plan, pursuant to a stock option agreement dated July 11, 2010 (the "2010 Stock Option Agreement"). The options are fully vested and exercisable as of the reporting date.
( 4)  Represents ten year non-qualified stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the 2008 Plan, pursuant to a stock option agreement dated August 31, 2012 (the "2012 Stock Option Agreement"). The options will vest annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013, provided that the Reporting Person has been continuously a Service Provider (as defined in the 2012 Stock Option Agreement) from August 31, 2012 until the date such vesting occurs.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Yang Gang CBPO
C/O CBPO, 18F, JIALONG INT'L TOWER,
19 CHAOYANG PARK RD.
BEIJING, F4 100125


Corporate Vice President

Signatures
/s/Yang, Gang CBPO 8/26/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more China Bioligic Products Charts.
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more China Bioligic Products Charts.